Merrimack Pharmaceuticals Inc
MACKDelisted May 10, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001274792
Merrimack Pharmaceuticals Inc was delisted on May 10, 2024; its insiders filed their last Form 4 on Dec 28, 2023; 70 institutions reported holding it in 13F filings for Q1 2024, worth $137.1M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Merrimack Pharmaceuticals Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 42 | 41 | −1 |
| Shares | 8.06M | 8.01M | −51.8K (−0.6%) |
| Value | $48.0M | $30.0M | −$17.9M (−37.4%) |
New holders (2)
Institutions that held Merrimack Pharmaceuticals Inc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Belvedere Trading LLC | 20,052 | $77.0K | 0.08% |
| FMR LLC | 1 | $0 | 0.00% |
Sold out (3)
Institutions that held Merrimack Pharmaceuticals Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Bronte Capital Management Pty Ltd. | 578,313 | $3.44M |
| Goldman Sachs Group Inc | 14,142 | $84.0K |
| Cubist Systematic Strategies, LLC | 800 | $5.00K |